AFB (TB) – Antibiogram for MTb Complex – Cycloserine Drug by Conventional LJ – Pure Growth of MTB Complex

This test measures the susceptibility of the tuberculosis bacteria (MTB complex) to cycloserine.

• This test is primarily done to assess the drug susceptibility of tuberculosis bacteria. • To guide the selection of appropriate medications for tuberculosis treatment • To monitor the effectiveness of ongoing tuberculosis treatment • To identify drug-resistant strains of tuberculosis

This test is typically recommended when a person has • A suspected or confirmed diagnosis of tuberculosis • An inadequate response to previous tuberculosis treatment • Symptoms suggestive of drug-resistant tuberculosis • A history of exposure to drug-resistant tuberculosis

The test provides information about the susceptibility of tuberculosis bacteria to cycloserine. Abnormal results may suggest drug resistance.

During this test, a sputum or other appropriate specimen will be collected to be sent to a laboratory for testing for drug susceptibility.

Please reach out to your healthcare provider for any specific requirements.

• GeneXpert MTB/RIF assay: Detects the presence of tuberculosis bacteria and determines rifampicin resistance • Culture and sensitivity testing: Helps identify tuberculosis bacteria and assess their susceptibility to various drugs • Chest X-ray: Provides an image of the lungs to evaluate tuberculosis-related changes

MTB complex drug susceptibility testing for cycloserine by conventional LJ culture

Tuberculosis (TB) is an infectious disease caused by the bacteria Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other parts of the body. TB spreads through the air when an infected person coughs or sneezes. Early detection and appropriate treatment are crucial to prevent its spread and manage the disease effectively.